Trial Profile
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Sponsors Intercell USA; Valneva USA
- 11 Dec 2017 According to a Valneva media release, Intercell USA changed its name to Valneva USA.
- 06 May 2014 New trial record